CD274 and lung carcinoma: Median percentage of PD-L1 positive cells among the CETCs was 68.9 (range: 0-100) in breast, 65.8 (range: 32-100) in prostate, 57 (range: 0-90.5) in colorectal and 55 (range 0-90) in lung cancer.